AU2002338309A1 - Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease - Google Patents

Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease

Info

Publication number
AU2002338309A1
AU2002338309A1 AU2002338309A AU2002338309A AU2002338309A1 AU 2002338309 A1 AU2002338309 A1 AU 2002338309A1 AU 2002338309 A AU2002338309 A AU 2002338309A AU 2002338309 A AU2002338309 A AU 2002338309A AU 2002338309 A1 AU2002338309 A1 AU 2002338309A1
Authority
AU
Australia
Prior art keywords
adenosine
parkinson
disease
treatment
receptor antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002338309A
Inventor
Karin Sandager Nielsen
Dan Peters
Lars Christian Ronn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NTG Nordic Transport Group AS
Original Assignee
Neurosearch AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch AS filed Critical Neurosearch AS
Publication of AU2002338309A1 publication Critical patent/AU2002338309A1/en
Abandoned legal-status Critical Current

Links

AU2002338309A 2001-04-09 2002-04-04 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease Abandoned AU2002338309A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200100583 2001-04-09

Publications (1)

Publication Number Publication Date
AU2002338309A1 true AU2002338309A1 (en) 2002-10-21

Family

ID=

Similar Documents

Publication Publication Date Title
WO2005097140A3 (en) Selective antagonists of a2a adenosine receptors
PT2942082T (en) A2a receptor antogonists for use in the treatment of movement disorders
HUP0401777A3 (en) 3h-[1,2,4]triazolo[5,1-i]purin-5-yl amines as adenosine a2a receptor antagonists and pharmaceutical compositions containing the compounds
PL377239A1 (en) Novel amino-substituted dihydropyrimido[4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
HUP0401987A3 (en) Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
MXPA03009185A (en) Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson s disease.
NZ522326A (en) Adenosine A2A receptor antagonists
HUP0402270A3 (en) [1,2,4]triazolo[1,5-c]pyrimidin-5-yl-amines as adenosine a2a receptor antagonists and pharmaceutical compositions containing them
IL162596A0 (en) 1-Alkyl-1-azoniabicyclo Ä2.2.2Ü octane carbamate derivatives and their use as muscarinic receptor ntagonists
PL353969A1 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands
HUP0401047A3 (en) Triazolo[4,5-d]pyrimidine derivatives, their use as purinergic receptor antagonist and pharmaceutical compositions containing same
HK1064097A1 (en) Bicyclic Ä1,2,4Ü -triazole adenosine a2a receptor antagonists
AU2003251471A1 (en) Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5)
HK1063780A1 (en) Adenosine a2a receptor antagonists
WO2001039777A8 (en) Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof
HUP0400988A3 (en) Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
IL160402A0 (en) Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido {1,2-a} pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-pyrimidin-5 (1h) one derivatives
WO2004092171A3 (en) Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosin e receptor antagonists
HUP0203371A3 (en) Adenosine receptor antagonists and methods of making and using the same
HUP0401444A3 (en) Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity, use of the compounds and pharmaceutical compositions containing the same
PL370565A1 (en) 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists
TWI320413B (en) 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof
WO2004092172A3 (en) Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosin e receptor antagonists
AU2002338309A1 (en) Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease
AU2003238057A1 (en) Human receptor tyrosine kinase mertk